BioWorld

Oct. 13, 2005

View Archived Issues

Range Of Reasons For Animal Cloning: Heroic To Narcissistic

Read More

Celldex Buying Two Firms; IPO Plans Still On Horizon

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

Positive Tadalafil Data In BPH Starts Phase III Plans For ICOS

Lilly ICOS LLC plans to move tadalafil into a Phase III program for benign prostatic hyperplasia after it reached statistical significance in a Phase II proof-of-concept study. (BioWorld Today) Read More

Raven's Series D: $48M For RAV12 Cancer Trials

Read More